WCM
CTSO icon

Weld Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Weld Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,632
Closed -$115K – 515
2020
Q2 		$115K Buy
+11,632
New +$107K 0.05% 429

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weld Capital Management's CTSO Position: Q3 2020 in Review

Weld Capital Management sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 11,632 shares — an estimated $115K sold.

Weld Capital Management first reported a position in CTSO in Q2 2020 and held it in 1 quarter. The position peaked at $115K in Q2 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • Weld Capital Management reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 11,632 Cytosorbents Corp shares in Q3 2020, an estimated $115K.
  • Weld Capital Management first reported a position in Cytosorbents Corp in Q2 2020 and held it in 1 quarter.
  • Weld Capital Management's Cytosorbents Corp position peaked at $115K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.